chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Approx 32 hrs post vaccination patient had symptoms of backache, headache, body aches, dizziness, skin sensitivity, shivering, chills. She stated she was "groaning in pain all night long". Pain was radiating up arms into neck and jaw. She took baby aspirin and extra strength Tylenol q 4-6 hours. Called MD and they stated these were normal symptoms and she did not need to be seen. Symptoms lasted another 1 1/2 days and resolved.  She stated she "felt fine" by day 3 post vaccination.
p/vax rash noted on chest 10/8/99;spread ;temp to 104-rash all over body 10/10/99;
Patient was technically a resident of retirement community, however, he chose to live independently at home at his current home. Only his spouse actually resides at retirement community.   Patient received the second dose of the Moderna vaccine via pharmacy vaccination clinic at retirement community on 2/3/2021. He was found deceased in his home by a certified nursing assistant on 2/4/2021 at approximately 10:00am.
PIN-PAIN IN ARM; SEVERE CHILLS/ CHATTERING TEETH; This spontaneous report received from a patient concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown and expiry: unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the patient experienced pin-pain in arm, and severe chills/ chattering teeth. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the pin-pain in arm and severe chills/ chattering teeth was not reported. This report was non-serious.
per mom went home that day after vaccines, was fine until suddenly went into shaking spell, per mom last 10-15 minutes of shaking and eye rolling, per mom pt was unresponsive to her and did not stop when she picked her up and even tried patting her back, per mom called squad and since had stopped by time arrived and was afebrile they didn't take her in, per mom has been fine since, has not had any similar episodes before or after event
Expired vaccine used; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) in a 72-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Oct-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Expired vaccine used). On 13-Oct-2021, EXPIRED PRODUCT ADMINISTERED (Expired vaccine used) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment details were provided.  The vaccine was manufactured on 09 Mar 2021. Delivered at vaccination center on 30 Sep 2021. Patient did not experience adverse event.
This spontaneous report was received from a medical assistant and refers to two unspecified patients of unknown age or gender. Pertinent medical history or drug allergies/drug reactions were not reported. On an unknown date, the patients were vaccinated with improperly stored doses of GARDASIL 9 (lot reported as K006960, expiration date 19-FEB-2017) (dose, strength and route of administration were not reported). There was not concomitant medication reported. No adverse experiences were reported. Additional information has been requested. Lot number K006960 is an invalid lot number for GARDASIL 9.
Crying unconsolably 2-3 hours after receiving vax. fever lethargy, decreased feeding, local swelling and redness at the site of vax. All sx subsided 24-36 hours post. Followed by generalized erythematous macular rash all over the body.
SWELLING ON BOTH LEGS AND THIGHS; This spontaneous report received from a pharmacist concerned a 52 year old male. The patient's height, and weight were not reported. The patient's pre-existing medical conditions included the patient had no known medical condition. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 042A21A, and expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 for prophylactic vaccination. No concomitant medications were reported. On APR-2021, the subject experienced swelling on both legs and thighs. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from swelling on both legs and thighs. This report was non-serious.
Rash at injection site, Severe pain ophthalmic shingles, vertigo, ear pain, burning sensation on scalp and face. 3+ weeks with no relief from medication therapy. Taking acyclovir, Lyrica.
Pt called complaining of pain and swelling in the left arm and a fever of 103 F.
2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.; No adverse event; This spontaneous case was reported by a pharmacist and describes the occurrence of WRONG PRODUCT ADMINISTERED (2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.) and NO ADVERSE EVENT (No adverse event) in a kid patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 011H22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced WRONG PRODUCT ADMINISTERED (2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.) and NO ADVERSE EVENT (No adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        The action taken with mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown) was unknown.   For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.).    No Concomitant medication was reported.  It was reported that 2 pediatric siblings came in to start the Moderna Covid-19 Primary series. They both received the Moderna bivalent booster instead.  No treatment information was provided.   This case was linked to US-MODERNATX, INC.-MOD-2023-710203 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-710203:Master case
2 Minutes after vaccine administration pt. had seizure activity, no history of seizure, although she does have a family h/o seizure disorder. Seizure resolved after about 30 seconds
This case was reported by a physician and described the occurrence of hives in a 29 year old female subject who was vaccinated with influenza virus vaccine (Fluarix, GlaxoSmithKline) for prophylaxis. The subject's medical history included exposure to tuberculosis and penicillin allergy - urticaria. Concurrent medications included Ortho Tri-Cyclen (Orthotricyclen), Pantoprazole (Protonix), Methylphenidate hydrochloride (Ritalin)Methylphenidate hydrochloride (Concerta) and pyridoxine hydrochloride (Vitamin B6). Concurrent medication also included "9 months of Isoniazid therapy which will conclude in May 2007." The subject had received influenza virus vaccine in previous years with no subsequent adverse events. On 19, October 2006 at 12:00 p.m., the subject received unspecified dose of Fluarix in the left arm. the "evening of " 19, October 2006, less than one day after vaccination with Fluarix, the subject experienced hives and itching all over her body and angioedema. The physician considered the events were life threatening and clinically significant (or requiring intervention). The subject was treated with diphenhydramine (Benadryl). Approximately one month after receipt of Fluarix, on an unspecified date in November 2006, the subject was seen by an physician for skin testing. The skin testing revealed positive skin reactions to Fluarix and to gentamicin. The physician stated that the subject "cannot recall ever having an exposure to gentamicin" and that gentamicin is, "contained within Fluarix." The events resolved on an unspecified date on or before 24, January 2007. Follow-up was received from the reporting physician on 09, February 2007. Medical history also included non-smoker and non-drinker. The event of angioedema was clarified to facial and laryngeal edema. The events resolved on 20 October 2006. The physician considered the events to possibly be related to vaccination with Fluarix.
2 weeks after 2nd dose of Rotateq administered-2 episodes of bloody stools.
possible administration of 2nd dose outside of the dosing interval of 42 days; This spontaneous case was reported by an other health care professional and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-May-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (possible administration of 2nd dose outside of the dosing interval of 42 days) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient received the first dose of the Moderna COVID-19 Vaccine back in March. No Concomitant  information was  provided. No Treatment information was  provided.
sick; This case was reported and described the occurrence of sickness in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced sickness. On an unknown date, the outcome of the sickness was recovered/resolved.   It was unknown if the reporter considered the sickness to be related to Shingles vaccine.   Additional details were reported as follows: The case was reported by the patient. The age at vaccination was not reported. The shot and the side effects made the patient sick for almost a week. No contact details were reported.
Patient was given 5-11 pfizer bivalent of covid vaccine instead of the monovalent second dose. Patient tolerated and had no reaction.
24 hours later patient had her tongue and face start swelling. increased pressure in her sinuses. lasted 6-8 hours and went away
Johnson and Jonson vaccine given in my left arm.  Within 5 minutes I passed out cold.  When I came too I almost passed out again.  The strange thing was that I was having a hard time not passing out for at least 10 minutes after this shot.  I have never experienced this before.  I had no energy for the rest of the night.  By the next day I had a fever and felt like i had the flu for over 24 hours.  My husband did as well but he did not pass out.
No adverse event reported by pt, error found in facility vaccine stock indicating a probable administration of two liquid components of Menveo vaccine with no dry component mixed in.  Unable to determine which documented  pt may have received the erroneous dose.  Will re-vaccinate patient to ensure appropriate immunity.
Vaccine adminstered to unapproved age group. Given to confirmed 9 year old. Patient's chart stated patient was older than really was, unknown if system error or deliberate misleading
Severe premenstrual cramping that lasted 30+minutes - at the time I did not know what it was because I have never had prementrual cramping. Cycle started the following morning, which was 6 days early. I did not have cramps on my first day, which is abnormal.  Cycle was almost the same except spotting for a few extra days more than normal.
Patient presented with wide spread rash around injection site. Treating with cortisone - not terribly troublesome to pt but itching.
Rash in her face, neck and chest.; This spontaneous case was reported by a dental hygienist and describes the occurrence of RASH (Rash in her face, neck and chest.) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 10-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, the patient experienced RASH (Rash in her face, neck and chest.). At the time of the report, RASH (Rash in her face, neck and chest.) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medication list was not provided. Treatment information was not provided. Action taken with mRNA-1273 in response to the event was not applicable. The patient reported that the rash went away as soon as it came.
pain at injection site; a really stiff arm for 3 days; Initial information regarding an unsolicited valid non-serious case was received from a consumer or non-health care professional via Medical Information (Reference number- 00613107) and transmitted to Sanofi on 24-May-2021.  This case involves an unknown age female patient who experienced really stiff arm for 3 days (musculoskeletal stiffness), pain at injection site (vaccination site pain), when received INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE [FLUZONE HIGH-DOSE QUADRIVALENT].  The patient's past medical treatment included WITCH HAZEL [HAMAMELIS VIRGINIANA EXTRACT] having reaction of rash, KEFLEX [CEFALEXIN] with adverse reaction of egg allergy, arm swelling, VIOXX with vomiting, rash, LEVAQUIN with vomiting, rash, intravenous (IV), ANTIHISTAMINES which dries out eyes and mouth, MIDODRINE with edema, weight gain HCTZ having hypotension, PENICILLIN [PENICILLIN NOS], ERYTHROMYCIN and SULFA [SULFACETAMIDE SODIUM], , IVP dyes with hives, flushing, vomiting  The patient's past vaccination included INFLUENZA VACCINE with adverse reaction of egg allergy, arm swelling for prophylactic vaccination.  The patient's past medical history, concomitant medication and family history were not provided.  At the time of the event, the patient had ongoing allergy to COVID-19 vaccine and cardiac disorder.  In 2020, the patient received a dose of suspect INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE (lot and expiry date not reported), via an unknown route at an unknown administration site for prophylactic vaccination.  On an unknown date the patient developed a non-serious a really stiff arm (musculoskeletal stiffness) and pain at injection site (vaccination site pain) for 3 days (unknown latency) following the administration of INFLUENZA QUADRIVAL A-B HIGH DOSE HV VACCINE.  Caller want to check ingredients in the flu shot to see if there are any of those ingredients as are in the Covid vaccine. Consumer who asks if sucrose, glycerin and glycerol are in Fluzone HD. She reports potential adverse event for Fluzone HD for multiple medicine  She also reported she has a T wave abnormality on ECG and valve prolapse.  It was not reported if the patient received a corrective treatment for the events.  On an unknown date, the patient recovered from both the events after 3 days.  Reporter does not relate both adverse event musculoskeletal stiffness and vaccination site pain to Fluzone HD, but to a general medical cardiac history.  There will be no information available on the batch number for this case.
Muscle aches; Joint pain; Headache; Extreme dizziness; Extreme fatigue; Dose 1: 01Apr2021 and Dose 2: 15Apr2021; This is a spontaneous report from a non-contactable consumer, the patient. A 33-year-old female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 14:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation.  It was unknown, if the patient was pregnant at the time of this report. Medical history was not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications were not reported. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 01Apr2021 at 14:45 as a single dose for COVID-19 immunisation. On 16Apr2021 at 04:30, the patient experienced muscle aches, joint pain, headache, extreme dizziness and extreme fatigue. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events muscle aches, joint pain, headache, extreme dizziness and extreme fatigue was resolving at the time of this report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days; administered moderna vaccines beyond the use date and/or expired; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Oct-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Oct-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days). At the time of the report, EXPIRED PRODUCT ADMINISTERED (administered moderna vaccines beyond the use date and/or expired) and PRODUCT STORAGE ERROR (Vaccines were kept frozen until they are ready for administration means they would be in fridge about 1-3 days) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  It was mentioned in the report that the vaccines were tend to store with 1 to 3 bottles in the fridge to thaw out and to be ready for the patients when needed and at worst scenarios vaccines would have been in the fridge for about a week if no one came in to be vaccinated.  Treatment details were not reported by the reporter.
On 12/27/2022 I was on a cruise ship, and I had a slight fever, fatigue and cough. I did a COVID-19 test and it was positive. I seen the medical on the ship and I was prescribed acetaminophen and cough syrup. I also had to isolate for 5 days on the ship in my cabin. I was monitored throughout the 5 days of isolation.
Extreme exhaustion and weakness. Loss of appetite. Incontinence. Inability to participate in activities of daily living. Possible stroke. Amnesia. Delerium.  Visited Dr on March 1st. Bloodwork taken.  Bloodwork showed high white blood cell count. On 3/2/21, Doctor advised patient to go to ER but patient refused.  Urine sample dropped off on 3/3/21. Urinalysis showed bacteria in urine. Doctor prescribed cephalexin for possible UTI and ordered brain MRI without contrast. Patient is still exhausted and sleeping a great deal. Appetite is improving. Additional information for Item 18:  Patient cannot remember any events between February 24-March 9, 2021. MRI done on 3/12/21. Waiting on results of MRI. Switched primary care on 3/12/21.
Pt had second hep B shot 9/16/04. Six hours later, area at left upper arm got red, itchy and raised and hard. Area approximatley 1-1.5 inches in diameter. Still red, raised, itchy on 9/20/04 when patient treated at student health service.
12/8/2022 early morning I had a scratchy throat with sinus congestion and nasal drainage.  Later that day I had a slight fever of 99.3.  Tested positive on an At Home COVID-19 test.  12/9 Televisit with doctor.  Who advised to treat symptomatically.  12/12 patient started to feel better, symptoms greatly diminished, but had been steady until that point.  By 12/13 patient reports being back to normal.  Continued to test on At Home COVID-19 tests until 12/18 when I finally tested negative.
Pt arrived at 3pm for the pfizer booster vaccine. Three minutes following the vaccination the pt began to c/o chest tighness, hives, itching, redness and a hard time breathing. Pt was visably sweating, shivering with redness and hives present on chest upon assessment. Vitals were taken and as follow; BP 144/76,  HR 115, Temp 97.2 and O2 sat 100%. An EpiPen was administered as Dr was called to assess the situation. During the evaluation, the pt chest pain began to worsen and Dr. insisted EMS Services. The on staff RN called 911 and EMS arrived within 5 mins. Pt information was given by RN and the pt was taken to ED.
Normal sore arm that evening before bedtime  Took two Tylenol at bedtime around 1030 pm Woke up 330 am with dizzy fainting nausea  Passed out twice on bathroom floor plus on toilet  husband had to hold me up both times     Extreme vomiting and nausea chill?s and diarrhea  and headache no fever on thermometer  Starting to clear now still upset stomach but no vomiting  2;15 pm  September 11th
Symptoms started with a cough that after 4 hours became a restrictive cough c/o headache and fatigue. Difficulty going to sleep that night due to cough and tightness of airway used Albuterol inhaler a total of 3 times, symptoms resolving 24 hours later. Albuterol is pt's own medication.
Within 7-8 hours after receiving the vaccine I had a bad headache, fatigue, back ache and could hardly move. About 12-14 hours in, I experienced diarrhea, a high fever (103 degrees) and vomiting. There was nothing in my stomach, so I would dry heave for 24 hours. My resting heart rate is generally between 55-65 bpm. I have had days where my resting heart rate will jump to 180.
Pain in my arm where I got the shot, dizziness, EXTREME FATIGUE that lasted for two days, severe  headache, joint pain especially in right shoulder, body aches & the chills